Tyrosine phosphorylation of Downstream of kinase 3 (Dok-3) plays crucial role in Leishmania donovani infection by regulating inhibitory proteins, SH-PTP-1 and SHIP-1 in macrophages
This study demonstrates that tyrosine phosphorylation of the adaptor protein Dok-3 is essential for restricting *Leishmania donovani* infection in macrophages by facilitating its interaction with inhibitory phosphatases SHIP-1 and SHP-1, thereby regulating p38 MAPK–STAT1 signaling and endosomal trafficking to limit parasite survival.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human body, macrophages act as vigilant sentinels, patrolling the tissues to engulf and destroy invading pathogens. When a microscopic parasite called Leishmania donovani enters the bloodstream through a sandfly bite, it is quickly swallowed by these immune cells. However, this parasite is a master of disguise. Once inside, it does not simply wait to be destroyed; instead, it hijacks the cell's internal communication systems, turning off the very alarms that should trigger its elimination. This subversion leads to visceral leishmaniasis, a severe and often fatal disease that affects millions of people worldwide. Understanding exactly how the parasite disables the immune system, and conversely, how the cell might fight back, is crucial for developing new ways to treat the infection.
A team of researchers at the University of Calcutta and St. Xavier's College in Kolkata has uncovered a specific molecular mechanism that determines whether a macrophage successfully defends itself or falls victim to the parasite. They focused on a protein called Dok-3, which acts as a signaling hub inside the cell. Under normal circumstances, when a macrophage encounters a threat, Dok-3 undergoes a chemical change known as tyrosine phosphorylation. This process is like flipping a switch that allows Dok-3 to grab onto other important proteins, specifically two enzymes named SHIP-1 and SHPTP-1, which help regulate the cell's response. The researchers wanted to know if this chemical switch was essential for stopping Leishmania or if the parasite could bypass it.
To find the answer, the scientists created two types of laboratory mouse macrophages. One group contained the normal, fully functional Dok-3 protein. The other group was engineered with a broken version of the protein, Dok-3_4F, which lacked the specific sites needed for that crucial chemical switch to flip. They then infected both groups with Leishmania donovani. The results were stark. The macrophages with the broken protein were unable to control the infection. They harbored significantly higher numbers of parasites compared to the cells with the normal protein. In fact, as time passed, the cells with the defective Dok-3 became overwhelmed, while the healthy cells managed to keep the parasite load low. This demonstrated that the ability of Dok-3 to undergo tyrosine phosphorylation is a critical defense mechanism that the parasite tries to evade.
The study went deeper to explain why the broken protein failed. Using advanced computer modeling to visualize the molecular shapes, the researchers observed that when Dok-3 is properly phosphorylated, it changes its shape in a way that creates a much larger and more stable docking site for the SHIP-1 enzyme. This strengthened connection allows the cell to recruit the necessary tools to fight the infection. The model also revealed a new interaction: phosphorylated Dok-3 binds tightly to SHPTP-1 as well, a connection that had not been previously identified in macrophages. Without the chemical switch, the broken Dok-3 protein could not hold onto these enzymes effectively, leaving the cell's defense systems disorganized.
This failure to recruit the right enzymes had a direct impact on the cell's internal signaling pathways. In the healthy cells with functional Dok-3, the infection triggered a protective chain of events involving specific signaling molecules that activate the cell's killing mechanisms. In the cells with the broken protein, this protective pathway was weak, while a different pathway that usually helps the parasite survive remained overly active. Furthermore, the researchers tracked the physical movement of the parasites inside the cells. In healthy macrophages, the parasites were guided into specific compartments where they could be destroyed. In the defective cells, the parasites were stuck in the wrong locations, unable to reach the cellular machinery needed to kill them.
The findings suggest that the parasite likely uses its own enzymes to cut or disable the Dok-3 protein, preventing the chemical switch from flipping and thus stopping the immune system from activating its full defense. By identifying this specific molecular checkpoint, the study highlights a potential new target for treatment. If future therapies can help restore or mimic the phosphorylation of Dok-3, it might be possible to force the macrophage to recognize the parasite and destroy it, offering a new strategy to combat visceral leishmaniasis. The work confirms that the battle against this parasite is not just about the strength of the immune cell, but about the precise chemical signals that tell the cell how to fight.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.